Literature DB >> 15151618

Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.

Kimihiro Shimo1, Motowo Mizuno, Junichirou Nasu, Sakiko Hiraoka, Chiho Makidono, Hiroaki Okazaki, Kazuhide Yamamoto, Hiroyuki Okada, Teizo Fujita, Yasushi Shiratori.   

Abstract

BACKGROUND: Altered expression of three complement regulatory proteins, decay-accelerating factor (CD55), membrane cofactor protein (CD46) and homologous restriction factor 20 (CD59) has been identified in human gastrointestinal malignancies, but their expression in esophageal cancer has not been described. Therefore the purpose of the present paper was to study the distribution of these proteins in human normal and malignant esophageal mucosa. METHODS AND
RESULTS: In the normal esophageal mucosa, CD55 predominantly stained on the cell membrane of squamous epithelium in the superficial and prickle cell layers, whereas CD46 most intensely stained on the cell membrane in the basal and parabasal cell layers. In contrast to this reciprocal expression of CD55 and CD46, CD59 was broadly distributed on the cell membrane in all layers. In the esophageal squamous cell carcinoma, CD55 staining was intense in the stroma but was negligible in the cancer cells. In contrast, CD46 and CD59 stained almost uniformly on the tumor cell membrane. There was a significant difference in the intensity of the staining of CD55 and CD46 among cells in various layers of normal esophageal mucosa and esophageal carcinoma cells, but not in the staining of CD59. Similar expression patterns of the three complement regulatory proteins in carcinoma cells and in normal epithelium in the basal and parabasal cell layers were observed.
CONCLUSIONS: These observations on the expression of the three complement regulatory proteins would help understanding of the host immune responses involving the complement system against esophageal squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15151618     DOI: 10.1111/j.1440-1746.2003.03328.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma.

Authors:  Shao-Liang Han; Chang Xu; Xiu-Ling Wu; Jun-Lin Li; Zhi Liu; Qi-Qiang Zeng
Journal:  Int J Colorectal Dis       Date:  2010-03-26       Impact factor: 2.571

Review 2.  Protein engineering to target complement evasion in cancer.

Authors:  Darrick Carter; André Lieber
Journal:  FEBS Lett       Date:  2013-11-14       Impact factor: 4.124

3.  Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.

Authors:  Yong Liu; Li Chen; Shu-You Peng; Zhou-Xun Chen; C Hoang-Vu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

4.  Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.

Authors:  Juan Carlos Varela; Carl Atkinson; Robert Woolson; Thomas E Keane; Stephen Tomlinson
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

5.  Immunosignature Screening for Multiple Cancer Subtypes Based on Expression Rule.

Authors:  Lei Chen; XiaoYong Pan; Tao Zeng; Yu-Hang Zhang; YunHua Zhang; Tao Huang; Yu-Dong Cai
Journal:  Front Bioeng Biotechnol       Date:  2019-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.